

[ Mon, Dec 12th 2016
] - WOPRAI

[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
[ Fri, Dec 09th 2016
] - WOPRAI
Seamus Fernandez Upgraded (AZN) to Buy on, Dec 9th, 2016
Seamus Fernandez of Leerink Swann, Upgraded "AstraZeneca PLC" (AZN) to Buy on, Dec 9th, 2016.
Seamus has made no other calls on AZN in the last 4 months.
There is 1 other peer that has a rating on AZN. Out of the 1 peers that are also analyzing AZN, 0 agree with Seamus's Rating of Hold.
This is the rating of the analyst that currently disagrees with Seamus
- David Toung of "Argus Research" Upgraded from Hold to Strong Buy on, Monday, August 29th, 2016
Contributing Sources